Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.

Bakris G, Calhoun D, Egan B, Hellmann C, Dolker M, Kingma I; orlistat and resistant hypertension investigators.

J Hypertens. 2002 Nov;20(11):2257-67.

PMID:
12409965
[PubMed - indexed for MEDLINE]
2.
3.

Orlistat: selective inhibition of caloric absorption can affect long-term body weight.

Hauptman J.

Endocrine. 2000 Oct;13(2):201-6. Review.

PMID:
11186221
[PubMed - indexed for MEDLINE]
4.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

PMID:
15147610
[PubMed - indexed for MEDLINE]
Free Article
5.

Orlistat: a review of its use in the management of obesity.

Hvizdos KM, Markham A.

Drugs. 1999 Oct;58(4):743-60. Review.

PMID:
10551441
[PubMed - indexed for MEDLINE]
6.

Review article: malnutrition and maltreatment--a comment on orlistat for the treatment of obesity.

Cahill A, Lean ME.

Aliment Pharmacol Ther. 1999 Aug;13(8):997-1002. Review.

PMID:
10468673
[PubMed - indexed for MEDLINE]
Free Article
7.

Orlistat: its current status as an anti-obesity drug.

Ballinger A, Peikin SR.

Eur J Pharmacol. 2002 Apr 12;440(2-3):109-17. Review.

PMID:
12007529
[PubMed - indexed for MEDLINE]
8.

Weight management and current options in pharmacotherapy: orlistat and sibutramine.

Leung WY, Thomas GN, Chan JC, Tomlinson B.

Clin Ther. 2003 Jan;25(1):58-80. Review.

PMID:
12637112
[PubMed - indexed for MEDLINE]
9.

Long-term effects of weight-reducing drugs in hypertensive patients.

Siebenhofer A, Jeitler K, Horvath K, Berghold A, Siering U, Semlitsch T.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD007654. doi: 10.1002/14651858.CD007654.pub3. Review.

PMID:
23543553
[PubMed - indexed for MEDLINE]
10.

Long-term effects of weight-reducing drugs in hypertensive patients.

Siebenhofer A, Horvath K, Jeitler K, Berghold A, Stich AK, Matyas E, Pignitter N, Siering U.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007654. doi: 10.1002/14651858.CD007654.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD007654.

PMID:
19588440
[PubMed - indexed for MEDLINE]
11.

New aspects in the management of obesity: operation and the impact of lipase inhibitors.

Uusitupa M.

Curr Opin Lipidol. 1999 Feb;10(1):3-7. Review.

PMID:
10095983
[PubMed - indexed for MEDLINE]
12.

Orlistat.

Wong NN, Cheng-Lai A.

Heart Dis. 2000 Mar-Apr;2(2):174-81. Review.

PMID:
11728255
[PubMed - indexed for MEDLINE]
13.

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.

Nelson RH, Miles JM.

Expert Opin Pharmacother. 2005 Nov;6(14):2483-91. Review.

PMID:
16259579
[PubMed - indexed for MEDLINE]
14.

Orlistat--a novel weight loss therapy.

Lucas KH, Kaplan-Machlis B.

Ann Pharmacother. 2001 Mar;35(3):314-28. Review.

PMID:
11261530
[PubMed - indexed for MEDLINE]
15.

Orlistat in the treatment of obesity.

Ballinger A.

Expert Opin Pharmacother. 2000 May;1(4):841-7. Review.

PMID:
11249520
[PubMed - indexed for MEDLINE]
16.

[The obesity epidemics--do diet pills have a place in the treatment?].

Tonstad S, Birkeland KI.

Tidsskr Nor Laegeforen. 2000 Jun 30;120(17):1997-2001. Review. Norwegian.

PMID:
11008533
[PubMed - indexed for MEDLINE]
17.

[Orlistat (Xenical)].

Crenier L, Sternon J.

Rev Med Brux. 1999 Jun;20(3):159-63. Review. French.

PMID:
10429540
[PubMed - indexed for MEDLINE]
18.

Orlistat.

McNeely W, Benfield P.

Drugs. 1998 Aug;56(2):241-9; discussion 250. Review.

PMID:
9711448
[PubMed - indexed for MEDLINE]
19.

[What is the evidence with regard to the effectiveness of orlistat?].

Nordmann A.

Schweiz Med Wochenschr. 2000 Apr 29;130(17):629-34. Review. German.

PMID:
10829301
[PubMed - indexed for MEDLINE]
20.

Orlistat, a new lipase inhibitor for the management of obesity.

Heck AM, Yanovski JA, Calis KA.

Pharmacotherapy. 2000 Mar;20(3):270-9. Review.

PMID:
10730683
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk